Co-Diagnostics (CODX) Expected to Announce Quarterly Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) is anticipated to announce its earnings results after the market closes on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.34) per share and revenue of $0.38 million for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Co-Diagnostics Stock Up 0.6 %

CODX stock opened at $0.46 on Tuesday. The company has a 50 day moving average of $0.64 and a two-hundred day moving average of $0.91. The company has a market cap of $14.80 million, a price-to-earnings ratio of -0.34 and a beta of 1.29. Co-Diagnostics has a 12-month low of $0.43 and a 12-month high of $2.23.

Co-Diagnostics Company Profile

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.